カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の静脈内（IV）溶液市場2022年：トータル非経口溶液、ペリフェラル非経口溶液

◆英語タイトル：Global Intravenous (IV) Solution Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8865）◆商品コード：GIR22MY8865
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

静脈内（IV）溶液市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の静脈内（IV）溶液の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

静脈内（IV）溶液市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・トータル非経口溶液、ペリフェラル非経口溶液

用途別セグメントは次のように区分されます。
・病院＆クリニック、外来、在宅医療

世界の静脈内（IV）溶液市場の主要な市場プレーヤーは以下のとおりです。
・ICU Medical、B. Braun Melsungen、Fresenius Kabi、Baxter、Amanta Healthcare、Terumo Medical、Grifols

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、静脈内（IV）溶液製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内（IV）溶液メーカーの企業概要、2019年～2022年までの静脈内（IV）溶液の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内（IV）溶液メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別静脈内（IV）溶液の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの静脈内（IV）溶液の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での静脈内（IV）溶液市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および静脈内（IV）溶液の産業チェーンを掲載しています。
・第13、14、15章では、静脈内（IV）溶液の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ICU Medical、B. Braun Melsungen、Fresenius Kabi、Baxter、Amanta Healthcare、Terumo Medical、Grifols
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：トータル非経口溶液、ペリフェラル非経口溶液
・用途別分析2017年-2028年：病院＆クリニック、外来、在宅医療
・静脈内（IV）溶液の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・静脈内（IV）溶液のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・静脈内（IV）溶液のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・静脈内（IV）溶液の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・静脈内（IV）溶液の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intravenous (IV) Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravenous (IV) Solution market size is estimated to be worth US$ 7922.8 million in 2021 and is forecast to a readjusted size of USD 10550 million by 2028 with a CAGR of 4.2% during review period. Hospitals & Clinics accounting for % of the Intravenous (IV) Solution global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Total Parenteral Solution segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravenous (IV) Solution include ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, and Amanta Healthcare, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravenous (IV) Solution market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Total Parenteral Solution
Peripheral Parenteral Solution
Market segment by Application can be divided into
Hospitals & Clinics
Ambulatory
Homecare
The key market players for global Intravenous (IV) Solution market are listed below:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous (IV) Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous (IV) Solution, with price, sales, revenue and global market share of Intravenous (IV) Solution from 2019 to 2022.
Chapter 3, the Intravenous (IV) Solution competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous (IV) Solution breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravenous (IV) Solution market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous (IV) Solution.
Chapter 13, 14, and 15, to describe Intravenous (IV) Solution sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Intravenous (IV) Solution Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous (IV) Solution Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Total Parenteral Solution
1.2.3 Peripheral Parenteral Solution
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous (IV) Solution Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory
1.3.4 Homecare
1.4 Global Intravenous (IV) Solution Market Size & Forecast
1.4.1 Global Intravenous (IV) Solution Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravenous (IV) Solution Sales in Volume (2017-2028)
1.4.3 Global Intravenous (IV) Solution Price (2017-2028)
1.5 Global Intravenous (IV) Solution Production Capacity Analysis
1.5.1 Global Intravenous (IV) Solution Total Production Capacity (2017-2028)
1.5.2 Global Intravenous (IV) Solution Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous (IV) Solution Market Drivers
1.6.2 Intravenous (IV) Solution Market Restraints
1.6.3 Intravenous (IV) Solution Trends Analysis
2 Manufacturers Profiles
2.1 ICU Medical
2.1.1 ICU Medical Details
2.1.2 ICU Medical Major Business
2.1.3 ICU Medical Intravenous (IV) Solution Product and Services
2.1.4 ICU Medical Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 B. Braun Melsungen
2.2.1 B. Braun Melsungen Details
2.2.2 B. Braun Melsungen Major Business
2.2.3 B. Braun Melsungen Intravenous (IV) Solution Product and Services
2.2.4 B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Intravenous (IV) Solution Product and Services
2.3.4 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Intravenous (IV) Solution Product and Services
2.4.4 Baxter Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Amanta Healthcare
2.5.1 Amanta Healthcare Details
2.5.2 Amanta Healthcare Major Business
2.5.3 Amanta Healthcare Intravenous (IV) Solution Product and Services
2.5.4 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Terumo Medical
2.6.1 Terumo Medical Details
2.6.2 Terumo Medical Major Business
2.6.3 Terumo Medical Intravenous (IV) Solution Product and Services
2.6.4 Terumo Medical Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business
2.7.3 Grifols Intravenous (IV) Solution Product and Services
2.7.4 Grifols Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravenous (IV) Solution Breakdown Data by Manufacturer
3.1 Global Intravenous (IV) Solution Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravenous (IV) Solution Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravenous (IV) Solution
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous (IV) Solution Manufacturer Market Share in 2021
3.4.2 Top 6 Intravenous (IV) Solution Manufacturer Market Share in 2021
3.5 Global Intravenous (IV) Solution Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravenous (IV) Solution Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous (IV) Solution Market Size by Region
4.1.1 Global Intravenous (IV) Solution Sales in Volume by Region (2017-2028)
4.1.2 Global Intravenous (IV) Solution Revenue by Region (2017-2028)
4.2 North America Intravenous (IV) Solution Revenue (2017-2028)
4.3 Europe Intravenous (IV) Solution Revenue (2017-2028)
4.4 Asia-Pacific Intravenous (IV) Solution Revenue (2017-2028)
4.5 South America Intravenous (IV) Solution Revenue (2017-2028)
4.6 Middle East and Africa Intravenous (IV) Solution Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intravenous (IV) Solution Sales in Volume by Type (2017-2028)
5.2 Global Intravenous (IV) Solution Revenue by Type (2017-2028)
5.3 Global Intravenous (IV) Solution Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intravenous (IV) Solution Sales in Volume by Application (2017-2028)
6.2 Global Intravenous (IV) Solution Revenue by Application (2017-2028)
6.3 Global Intravenous (IV) Solution Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous (IV) Solution Sales by Type (2017-2028)
7.2 North America Intravenous (IV) Solution Sales by Application (2017-2028)
7.3 North America Intravenous (IV) Solution Market Size by Country
7.3.1 North America Intravenous (IV) Solution Sales in Volume by Country (2017-2028)
7.3.2 North America Intravenous (IV) Solution Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous (IV) Solution Sales by Type (2017-2028)
8.2 Europe Intravenous (IV) Solution Sales by Application (2017-2028)
8.3 Europe Intravenous (IV) Solution Market Size by Country
8.3.1 Europe Intravenous (IV) Solution Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravenous (IV) Solution Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intravenous (IV) Solution Sales by Type (2017-2028)
9.2 Asia-Pacific Intravenous (IV) Solution Sales by Application (2017-2028)
9.3 Asia-Pacific Intravenous (IV) Solution Market Size by Region
9.3.1 Asia-Pacific Intravenous (IV) Solution Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravenous (IV) Solution Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intravenous (IV) Solution Sales by Type (2017-2028)
10.2 South America Intravenous (IV) Solution Sales by Application (2017-2028)
10.3 South America Intravenous (IV) Solution Market Size by Country
10.3.1 South America Intravenous (IV) Solution Sales in Volume by Country (2017-2028)
10.3.2 South America Intravenous (IV) Solution Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous (IV) Solution Sales by Type (2017-2028)
11.2 Middle East & Africa Intravenous (IV) Solution Sales by Application (2017-2028)
11.3 Middle East & Africa Intravenous (IV) Solution Market Size by Country
11.3.1 Middle East & Africa Intravenous (IV) Solution Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravenous (IV) Solution Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravenous (IV) Solution and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravenous (IV) Solution
12.3 Intravenous (IV) Solution Production Process
12.4 Intravenous (IV) Solution Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravenous (IV) Solution Typical Distributors
13.3 Intravenous (IV) Solution Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Intravenous (IV) Solution Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intravenous (IV) Solution Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 4. ICU Medical Major Business
Table 5. ICU Medical Intravenous (IV) Solution Product and Services
Table 6. ICU Medical Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 8. B. Braun Melsungen Major Business
Table 9. B. Braun Melsungen Intravenous (IV) Solution Product and Services
Table 10. B. Braun Melsungen Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi Major Business
Table 13. Fresenius Kabi Intravenous (IV) Solution Product and Services
Table 14. Fresenius Kabi Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Baxter Basic Information, Manufacturing Base and Competitors
Table 16. Baxter Major Business
Table 17. Baxter Intravenous (IV) Solution Product and Services
Table 18. Baxter Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Amanta Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Amanta Healthcare Major Business
Table 21. Amanta Healthcare Intravenous (IV) Solution Product and Services
Table 22. Amanta Healthcare Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 24. Terumo Medical Major Business
Table 25. Terumo Medical Intravenous (IV) Solution Product and Services
Table 26. Terumo Medical Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Grifols Basic Information, Manufacturing Base and Competitors
Table 28. Grifols Major Business
Table 29. Grifols Intravenous (IV) Solution Product and Services
Table 30. Grifols Intravenous (IV) Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Intravenous (IV) Solution Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Intravenous (IV) Solution Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Intravenous (IV) Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Intravenous (IV) Solution Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Intravenous (IV) Solution Production Site of Key Manufacturer
Table 36. Intravenous (IV) Solution New Entrant and Capacity Expansion Plans
Table 37. Intravenous (IV) Solution Mergers & Acquisitions in the Past Five Years
Table 38. Global Intravenous (IV) Solution Sales by Region (2017-2022) & (K Units)
Table 39. Global Intravenous (IV) Solution Sales by Region (2023-2028) & (K Units)
Table 40. Global Intravenous (IV) Solution Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Intravenous (IV) Solution Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 43. Global Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 44. Global Intravenous (IV) Solution Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Intravenous (IV) Solution Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Intravenous (IV) Solution Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Intravenous (IV) Solution Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 49. Global Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 50. Global Intravenous (IV) Solution Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Intravenous (IV) Solution Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Intravenous (IV) Solution Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Intravenous (IV) Solution Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
Table 55. North America Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
Table 56. North America Intravenous (IV) Solution Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Intravenous (IV) Solution Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 59. North America Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 60. North America Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 61. North America Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 62. Europe Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
Table 63. Europe Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
Table 64. Europe Intravenous (IV) Solution Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Intravenous (IV) Solution Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 67. Europe Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 68. Europe Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 69. Europe Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Intravenous (IV) Solution Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Intravenous (IV) Solution Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Intravenous (IV) Solution Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Intravenous (IV) Solution Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 78. South America Intravenous (IV) Solution Sales by Country (2017-2022) & (K Units)
Table 79. South America Intravenous (IV) Solution Sales by Country (2023-2028) & (K Units)
Table 80. South America Intravenous (IV) Solution Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Intravenous (IV) Solution Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 83. South America Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 84. South America Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 85. South America Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Intravenous (IV) Solution Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Intravenous (IV) Solution Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Intravenous (IV) Solution Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Intravenous (IV) Solution Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Intravenous (IV) Solution Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Intravenous (IV) Solution Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Intravenous (IV) Solution Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Intravenous (IV) Solution Sales by Application (2023-2028) & (K Units)
Table 94. Intravenous (IV) Solution Raw Material
Table 95. Key Manufacturers of Intravenous (IV) Solution Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Intravenous (IV) Solution Typical Distributors
Table 99. Intravenous (IV) Solution Typical Customers
List of Figures
Figure 1. Intravenous (IV) Solution Picture
Figure 2. Global Intravenous (IV) Solution Revenue Market Share by Type in 2021
Figure 3. Total Parenteral Solution
Figure 4. Peripheral Parenteral Solution
Figure 5. Global Intravenous (IV) Solution Revenue Market Share by Application in 2021
Figure 6. Hospitals & Clinics
Figure 7. Ambulatory
Figure 8. Homecare
Figure 9. Global Intravenous (IV) Solution Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Intravenous (IV) Solution Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intravenous (IV) Solution Sales (2017-2028) & (K Units)
Figure 12. Global Intravenous (IV) Solution Price (2017-2028) & (USD/Unit)
Figure 13. Global Intravenous (IV) Solution Production Capacity (2017-2028) & (K Units)
Figure 14. Global Intravenous (IV) Solution Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Intravenous (IV) Solution Market Drivers
Figure 16. Intravenous (IV) Solution Market Restraints
Figure 17. Intravenous (IV) Solution Market Trends
Figure 18. Global Intravenous (IV) Solution Sales Market Share by Manufacturer in 2021
Figure 19. Global Intravenous (IV) Solution Revenue Market Share by Manufacturer in 2021
Figure 20. Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Intravenous (IV) Solution Sales Market Share by Region (2017-2028)
Figure 24. Global Intravenous (IV) Solution Revenue Market Share by Region (2017-2028)
Figure 25. North America Intravenous (IV) Solution Revenue (2017-2028) & (USD Million)
Figure 26. Europe Intravenous (IV) Solution Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Intravenous (IV) Solution Revenue (2017-2028) & (USD Million)
Figure 28. South America Intravenous (IV) Solution Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Intravenous (IV) Solution Revenue (2017-2028) & (USD Million)
Figure 30. Global Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 31. Global Intravenous (IV) Solution Revenue Market Share by Type (2017-2028)
Figure 32. Global Intravenous (IV) Solution Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 34. Global Intravenous (IV) Solution Revenue Market Share by Application (2017-2028)
Figure 35. Global Intravenous (IV) Solution Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 37. North America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 38. North America Intravenous (IV) Solution Sales Market Share by Country (2017-2028)
Figure 39. North America Intravenous (IV) Solution Revenue Market Share by Country (2017-2028)
Figure 40. United States Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 44. Europe Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 45. Europe Intravenous (IV) Solution Sales Market Share by Country (2017-2028)
Figure 46. Europe Intravenous (IV) Solution Revenue Market Share by Country (2017-2028)
Figure 47. Germany Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Intravenous (IV) Solution Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Intravenous (IV) Solution Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intravenous (IV) Solution Revenue Market Share by Region (2017-2028)
Figure 56. China Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 63. South America Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 64. South America Intravenous (IV) Solution Sales Market Share by Country (2017-2028)
Figure 65. South America Intravenous (IV) Solution Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Intravenous (IV) Solution Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Intravenous (IV) Solution Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Intravenous (IV) Solution Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Intravenous (IV) Solution Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Intravenous (IV) Solution Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Intravenous (IV) Solution in 2021
Figure 77. Manufacturing Process Analysis of Intravenous (IV) Solution
Figure 78. Intravenous (IV) Solution Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の静脈内（IV）溶液市場2022年：トータル非経口溶液、ペリフェラル非経口溶液(Global Intravenous (IV) Solution Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の静脈内レーザー治療市場インサイト及び予測（静脈内レーザーシステム、静脈内レーザーファイバー）
  • 世界の完全埋め込み型静脈内投与装置（TIVAD）市場インサイト及び予測（チタン製ポートボディ、プラスチック製ポートボディ）
  • 世界の多機能点滴静注ロボット市場インサイト及び予測（固定型、携帯型）
  • 世界の静脈内注射免疫グロブリン市場2022年：1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml
  • 世界の静脈内ヒト免疫グロブリン市場2022年：液体、粉末